Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Shmuel Yaccoby

Concepts (332)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
63
2023
2954
5.010
 Why?
Osteoclasts
17
2015
428
2.600
 Why?
Bone Diseases
7
2014
99
2.340
 Why?
Osteoblasts
13
2012
450
1.510
 Why?
Gene Expression Regulation, Neoplastic
12
2018
828
1.330
 Why?
Osteolysis
6
2013
75
1.280
 Why?
Boronic Acids
12
2013
182
1.240
 Why?
Neoplasm Proteins
6
2018
324
1.230
 Why?
Coculture Techniques
12
2015
146
1.220
 Why?
Mice, SCID
17
2015
176
1.040
 Why?
Bone Marrow Cells
5
2015
190
1.030
 Why?
Cell Differentiation
14
2018
650
0.980
 Why?
Bone and Bones
9
2014
475
0.970
 Why?
Pyrazines
11
2013
187
0.930
 Why?
Bone Marrow
8
2018
363
0.870
 Why?
Cell Proliferation
11
2023
1013
0.820
 Why?
Mice
26
2015
5759
0.790
 Why?
Cell Communication
3
2015
69
0.780
 Why?
Intercellular Signaling Peptides and Proteins
4
2010
105
0.730
 Why?
Osteogenesis
5
2012
353
0.710
 Why?
Bone Resorption
4
2011
302
0.680
 Why?
Adipocytes
2
2018
121
0.660
 Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.650
 Why?
Animals
29
2016
13246
0.630
 Why?
Proteoglycans
4
2008
80
0.630
 Why?
Bone Neoplasms
2
2011
183
0.610
 Why?
Gene Expression
3
2018
609
0.590
 Why?
Humans
62
2023
50208
0.580
 Why?
Cell Movement
4
2013
249
0.560
 Why?
Antineoplastic Agents
9
2015
1186
0.560
 Why?
Neoplastic Stem Cells
1
2017
103
0.550
 Why?
Cell Survival
9
2015
602
0.540
 Why?
Protease Inhibitors
4
2010
58
0.540
 Why?
Tumor Microenvironment
2
2015
233
0.530
 Why?
Cytokines
3
2015
613
0.500
 Why?
Cysteine-Rich Protein 61
1
2014
3
0.480
 Why?
Plasma Cells
6
2009
223
0.460
 Why?
Nicotinamide Phosphoribosyltransferase
1
2013
5
0.440
 Why?
Angiogenesis Inhibitors
3
2010
188
0.430
 Why?
Membrane Glycoproteins
5
2009
246
0.420
 Why?
Protein-Tyrosine Kinases
1
2013
95
0.420
 Why?
Thalidomide
6
2016
377
0.410
 Why?
Mesenchymal Stem Cell Transplantation
1
2012
18
0.410
 Why?
Parathyroid Hormone
4
2010
147
0.390
 Why?
Gene Expression Profiling
7
2023
1037
0.390
 Why?
Up-Regulation
3
2013
453
0.390
 Why?
Wnt Proteins
2
2010
100
0.380
 Why?
Rabbits
5
2013
374
0.350
 Why?
Signal Transduction
6
2013
1622
0.350
 Why?
Receptor, EphB4
1
2009
5
0.340
 Why?
Ephrin-B2
1
2009
5
0.340
 Why?
Placenta
1
2011
132
0.340
 Why?
Fenretinide
1
2009
5
0.340
 Why?
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
1
2009
7
0.340
 Why?
Models, Biological
4
2010
723
0.330
 Why?
Disease Models, Animal
7
2016
1458
0.330
 Why?
Dipeptides
1
2009
22
0.330
 Why?
Cell Line, Tumor
9
2015
1416
0.330
 Why?
Antineoplastic Combined Chemotherapy Protocols
8
2016
990
0.320
 Why?
Cell Adhesion Molecules
1
2009
89
0.320
 Why?
Bone Development
1
2009
64
0.310
 Why?
Tumor Necrosis Factor Ligand Superfamily Member 13
1
2007
3
0.310
 Why?
Transmembrane Activator and CAML Interactor Protein
1
2007
6
0.310
 Why?
Extracellular Matrix Proteins
1
2008
69
0.300
 Why?
Apoptosis
8
2012
1112
0.300
 Why?
Disease Progression
6
2014
831
0.300
 Why?
Bone Remodeling
4
2012
149
0.290
 Why?
Recombinant Fusion Proteins
1
2007
186
0.280
 Why?
Neoplasm Recurrence, Local
3
2023
613
0.270
 Why?
Antibodies
1
2006
154
0.270
 Why?
Immunohistochemistry
5
2015
978
0.270
 Why?
Tumor Cells, Cultured
7
2013
468
0.260
 Why?
Serine Endopeptidases
1
2006
52
0.260
 Why?
RNA, Small Interfering
4
2013
215
0.260
 Why?
Transplantation, Heterologous
5
2009
75
0.260
 Why?
Antigens, Neoplasm
1
2006
152
0.250
 Why?
Prognosis
10
2018
1954
0.250
 Why?
Melphalan
2
2016
174
0.250
 Why?
Severe Combined Immunodeficiency
1
2005
12
0.250
 Why?
Neovascularization, Pathologic
4
2009
162
0.240
 Why?
Alkaline Phosphatase
6
2017
95
0.240
 Why?
NF-kappa B
4
2013
315
0.230
 Why?
Hematopoietic Stem Cells
3
2012
184
0.230
 Why?
Cell Division
5
2004
295
0.220
 Why?
Bone Density
3
2010
379
0.220
 Why?
Positron-Emission Tomography
2
2017
294
0.220
 Why?
Killer Cells, Natural
2
2015
107
0.210
 Why?
Translocation, Genetic
2
2021
264
0.210
 Why?
Stromal Cells
1
2003
72
0.210
 Why?
Transcription Factors
2
2023
564
0.210
 Why?
Immunophenotyping
2
2015
109
0.200
 Why?
Immunotherapy, Adoptive
2
2015
157
0.200
 Why?
Cell Line
2
2015
1021
0.190
 Why?
T-Lymphocytes
2
2015
339
0.190
 Why?
Epigenomics
1
2021
68
0.190
 Why?
Bone Transplantation
4
2010
47
0.180
 Why?
Decorin
2
2012
7
0.180
 Why?
Antibodies, Monoclonal
3
2016
460
0.180
 Why?
Female
17
2018
26635
0.170
 Why?
Drug Resistance, Neoplasm
2
2015
314
0.170
 Why?
Cells, Cultured
4
2013
1581
0.170
 Why?
Syndecan-1
4
2007
72
0.170
 Why?
Genes, myc
1
2019
41
0.160
 Why?
Risk Factors
5
2018
3629
0.150
 Why?
Mice, Transgenic
4
2007
550
0.150
 Why?
Cyclin-Dependent Kinases
2
2015
28
0.150
 Why?
Oligonucleotide Array Sequence Analysis
3
2009
411
0.150
 Why?
Diffusion Magnetic Resonance Imaging
1
2018
124
0.150
 Why?
Monoclonal Gammopathy of Undetermined Significance
2
2018
115
0.150
 Why?
Hexokinase
1
2017
17
0.150
 Why?
Tumor Suppressor Protein p53
2
2017
203
0.150
 Why?
Chromosomes, Human, Pair 17
1
2017
36
0.140
 Why?
Chromosome Aberrations
3
2016
297
0.140
 Why?
Calcification, Physiologic
1
2017
41
0.140
 Why?
Proteasome Inhibitors
2
2016
104
0.140
 Why?
Pelvis
1
2017
67
0.140
 Why?
Stem Cells
2
2009
171
0.140
 Why?
Chromosome Deletion
1
2017
140
0.140
 Why?
Biopsy
2
2018
590
0.140
 Why?
Neoplasm, Residual
1
2017
165
0.130
 Why?
Pyridinium Compounds
1
2015
19
0.130
 Why?
Neoplasms, Experimental
2
2007
114
0.130
 Why?
Male
14
2018
25399
0.130
 Why?
Base Sequence
2
2008
644
0.130
 Why?
Gene Expression Regulation, Enzymologic
1
2017
180
0.130
 Why?
Fluorodeoxyglucose F18
1
2017
194
0.130
 Why?
Endothelial Cells
2
2009
270
0.130
 Why?
Homologous Recombination
1
2015
41
0.130
 Why?
Benzimidazoles
1
2015
49
0.130
 Why?
Xenograft Model Antitumor Assays
3
2015
212
0.130
 Why?
Peptide Nucleic Acids
1
2015
17
0.130
 Why?
Rad51 Recombinase
1
2015
22
0.130
 Why?
Genes, Neoplasm
1
2015
30
0.130
 Why?
Bromodeoxyuridine
2
2005
19
0.130
 Why?
Immunologic Factors
1
2016
114
0.120
 Why?
Flow Cytometry
5
2012
476
0.120
 Why?
Genomic Instability
1
2015
93
0.120
 Why?
Diphosphonates
2
2008
90
0.120
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2006
595
0.120
 Why?
Antigens, CD
1
2015
221
0.120
 Why?
Asymptomatic Diseases
1
2014
36
0.120
 Why?
Proteome
1
2015
173
0.110
 Why?
Immunotherapy
1
2016
240
0.110
 Why?
Time Factors
6
2017
2922
0.110
 Why?
Interleukin-6
2
2005
265
0.110
 Why?
Nicotinamide Mononucleotide
1
2013
3
0.110
 Why?
Acrylamides
1
2013
6
0.110
 Why?
Receptors, CXCR4
1
2013
28
0.110
 Why?
Niacinamide
1
2013
22
0.110
 Why?
Poly(ADP-ribose) Polymerases
1
2013
30
0.110
 Why?
NAD
1
2013
43
0.110
 Why?
Enzyme Induction
1
2013
79
0.110
 Why?
Amides
1
2013
39
0.110
 Why?
Sirtuin 1
1
2013
28
0.110
 Why?
Chemokine CXCL12
1
2013
32
0.110
 Why?
Nitriles
1
2013
54
0.110
 Why?
Oligopeptides
1
2013
91
0.110
 Why?
beta Catenin
1
2013
102
0.110
 Why?
Tumor Burden
2
2010
131
0.110
 Why?
Recurrence
2
2012
662
0.110
 Why?
Enzyme Inhibitors
2
2013
386
0.110
 Why?
Gene Knockdown Techniques
1
2013
106
0.110
 Why?
Leukemia
1
2013
65
0.110
 Why?
Proteomics
1
2015
330
0.100
 Why?
Magnetic Resonance Imaging
2
2012
1541
0.100
 Why?
Myelodysplastic Syndromes
1
2013
81
0.100
 Why?
Injections, Intravenous
1
2012
143
0.100
 Why?
Proto-Oncogene Proteins c-jun
2
2009
75
0.100
 Why?
Piperidines
1
2013
98
0.100
 Why?
Cytotoxicity, Immunologic
1
2012
55
0.100
 Why?
Remission Induction
1
2012
207
0.100
 Why?
Syndecans
3
2006
34
0.100
 Why?
Anti-Inflammatory Agents
1
2012
160
0.090
 Why?
Aged
8
2017
9405
0.090
 Why?
Lymph Nodes
1
2012
263
0.090
 Why?
beta 2-Microglobulin
2
2007
38
0.090
 Why?
JNK Mitogen-Activated Protein Kinases
2
2007
72
0.090
 Why?
Middle Aged
9
2018
12206
0.090
 Why?
Disease-Free Survival
3
2018
454
0.090
 Why?
Early Growth Response Protein 1
1
2009
35
0.080
 Why?
Myocardium
1
2012
438
0.080
 Why?
Dexamethasone
3
2007
430
0.080
 Why?
Sphingosine
1
2009
26
0.080
 Why?
Lysophospholipids
1
2009
34
0.080
 Why?
Organoids
1
2009
40
0.080
 Why?
Prospective Studies
5
2016
2379
0.080
 Why?
Caspases
1
2009
104
0.080
 Why?
Drug Screening Assays, Antitumor
1
2009
140
0.080
 Why?
Leukocytes, Mononuclear
1
2009
115
0.080
 Why?
p38 Mitogen-Activated Protein Kinases
1
2009
96
0.080
 Why?
Enzyme Activation
1
2009
275
0.080
 Why?
Glucuronidase
2
2007
46
0.080
 Why?
Lentivirus
1
2008
16
0.080
 Why?
Wnt3 Protein
1
2008
7
0.080
 Why?
Immunoglobulin Light Chains
1
2009
82
0.080
 Why?
Ellipticines
1
2008
2
0.080
 Why?
Wnt3A Protein
1
2008
11
0.080
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
67
0.080
 Why?
Bone Density Conservation Agents
1
2009
74
0.080
 Why?
B-Cell Activating Factor
1
2007
3
0.080
 Why?
Precancerous Conditions
1
2008
83
0.080
 Why?
Cytological Techniques
1
2007
14
0.070
 Why?
Diploidy
1
2007
26
0.070
 Why?
Genetic Vectors
1
2008
125
0.070
 Why?
RNA Interference
1
2008
179
0.070
 Why?
Karyotyping
1
2007
83
0.070
 Why?
Phosphorylation
1
2009
534
0.070
 Why?
RNA, Messenger
2
2008
1108
0.070
 Why?
Heparan Sulfate Proteoglycans
1
2007
11
0.070
 Why?
Neoplasm Staging
2
2007
738
0.070
 Why?
Hematopoietic Stem Cell Transplantation
1
2012
567
0.070
 Why?
Reactive Oxygen Species
1
2009
408
0.070
 Why?
Mice, Inbred C57BL
1
2012
1819
0.070
 Why?
Phenotype
2
2009
733
0.070
 Why?
Immunosuppressive Agents
1
2008
222
0.070
 Why?
Models, Animal
1
2007
232
0.070
 Why?
Carrier Proteins
2
2008
306
0.070
 Why?
Risk Assessment
3
2018
1262
0.070
 Why?
Gelatinases
1
2006
32
0.070
 Why?
Endopeptidases
1
2006
66
0.070
 Why?
Antigens, CD19
1
2005
24
0.070
 Why?
Survival Analysis
2
2018
666
0.070
 Why?
Antigens, CD34
1
2005
66
0.060
 Why?
Fetal Tissue Transplantation
1
2005
10
0.060
 Why?
Hematologic Neoplasms
1
2006
99
0.060
 Why?
Molecular Sequence Data
1
2006
793
0.060
 Why?
Endothelium, Vascular
1
2006
254
0.060
 Why?
Receptor Activator of Nuclear Factor-kappa B
1
2004
30
0.060
 Why?
Annexin A5
1
2004
13
0.060
 Why?
Culture Media, Conditioned
1
2004
48
0.060
 Why?
Phagocytosis
1
2004
49
0.060
 Why?
Clinical Trials as Topic
3
2016
466
0.060
 Why?
Neoplasm Metastasis
1
2004
236
0.060
 Why?
Membrane Proteins
1
2006
353
0.060
 Why?
Polymerase Chain Reaction
1
2005
454
0.060
 Why?
Pregnancy
1
2011
2604
0.060
 Why?
Adult
5
2018
13324
0.050
 Why?
Endothelial Growth Factors
1
2002
9
0.050
 Why?
RANK Ligand
1
2004
179
0.050
 Why?
Vascular Endothelial Growth Factors
1
2002
15
0.050
 Why?
Lymphokines
1
2002
20
0.050
 Why?
Biotransformation
1
2002
85
0.050
 Why?
Oxidative Stress
1
2007
771
0.050
 Why?
Blotting, Western
2
2015
601
0.050
 Why?
Oncogenes
1
2021
57
0.050
 Why?
Vascular Endothelial Growth Factor A
1
2002
202
0.050
 Why?
Combined Modality Therapy
2
2016
636
0.050
 Why?
Imidazoles
1
2002
128
0.050
 Why?
Polycomb Repressive Complex 2
1
2021
47
0.050
 Why?
Chromatin
1
2021
152
0.050
 Why?
Liver Transplantation
1
2002
150
0.050
 Why?
Treatment Outcome
4
2017
5155
0.040
 Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
 Why?
Genes, Immunoglobulin Heavy Chain
1
2019
13
0.040
 Why?
Histones
1
2021
313
0.040
 Why?
Aged, 80 and over
2
2017
3154
0.040
 Why?
Radiography
2
2012
491
0.040
 Why?
In Situ Hybridization, Fluorescence
1
2019
259
0.040
 Why?
DNA-Binding Proteins
1
2021
428
0.040
 Why?
Tomography, X-Ray Computed
2
2017
1161
0.040
 Why?
False Positive Reactions
1
2017
62
0.040
 Why?
Metaphase
1
2016
44
0.040
 Why?
Liver
1
2002
1116
0.030
 Why?
Indolizines
1
2015
5
0.030
 Why?
Cyclic N-Oxides
1
2015
12
0.030
 Why?
Imaging, Three-Dimensional
1
2017
153
0.030
 Why?
Survival Rate
1
2018
901
0.030
 Why?
Transcriptome
1
2018
320
0.030
 Why?
Drug Synergism
1
2015
151
0.030
 Why?
S Phase
1
2015
19
0.030
 Why?
Genes, BRCA1
1
2015
19
0.030
 Why?
Follow-Up Studies
2
2013
2190
0.030
 Why?
Predictive Value of Tests
2
2007
905
0.030
 Why?
Enzyme-Linked Immunosorbent Assay
1
2015
244
0.030
 Why?
Transcription, Genetic
1
2015
369
0.030
 Why?
DNA Damage
1
2015
301
0.030
 Why?
Transfection
2
2004
355
0.030
 Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.030
 Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.030
 Why?
Interleukin-2
1
2012
72
0.030
 Why?
Acute Disease
1
2013
368
0.030
 Why?
Mice, Inbred NOD
1
2012
96
0.030
 Why?
Immunoenzyme Techniques
1
2012
145
0.020
 Why?
Lymphocyte Activation
1
2012
172
0.020
 Why?
Radiation-Sensitizing Agents
1
2010
53
0.020
 Why?
Inhibitor of Apoptosis Proteins
1
2009
20
0.020
 Why?
Incidence
1
2013
1006
0.020
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2009
12
0.020
 Why?
Protein Transport
1
2010
183
0.020
 Why?
Microtubule-Associated Proteins
1
2009
67
0.020
 Why?
Peptides
1
2010
223
0.020
 Why?
CDC2-CDC28 Kinases
1
2008
12
0.020
 Why?
Down-Regulation
1
2009
349
0.020
 Why?
Salvage Therapy
1
2008
139
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2009
225
0.020
 Why?
Protein Binding
1
2009
665
0.020
 Why?
Proteins
1
2010
345
0.020
 Why?
Antineoplastic Agents, Hormonal
1
2007
48
0.020
 Why?
Phospholipase C gamma
1
2006
4
0.020
 Why?
Cytogenetic Analysis
1
2007
82
0.020
 Why?
Caspase 9
1
2006
15
0.020
 Why?
Chi-Square Distribution
1
2007
278
0.020
 Why?
Cell Cycle
1
2008
232
0.020
 Why?
Multivariate Analysis
1
2008
581
0.020
 Why?
Mitogen-Activated Protein Kinase 3
1
2006
49
0.020
 Why?
Cyclin D
1
2006
18
0.020
 Why?
Osteoprotegerin
1
2006
52
0.020
 Why?
Bone Marrow Transplantation
1
2007
116
0.020
 Why?
Cyclins
1
2006
38
0.020
 Why?
RNA, Neoplasm
1
2006
45
0.020
 Why?
src-Family Kinases
1
2006
51
0.020
 Why?
Case-Control Studies
1
2009
1126
0.020
 Why?
Proto-Oncogene Proteins c-akt
1
2006
157
0.020
 Why?
Mice, Inbred BALB C
1
2006
305
0.020
 Why?
Chromosome Mapping
1
2006
156
0.020
 Why?
Phosphatidylinositol 3-Kinases
1
2006
140
0.020
 Why?
Cluster Analysis
1
2006
235
0.020
 Why?
Kaplan-Meier Estimate
1
2007
465
0.020
 Why?
Data Interpretation, Statistical
1
2006
157
0.020
 Why?
Transplantation, Autologous
1
2007
469
0.020
 Why?
Logistic Models
1
2007
889
0.020
 Why?
DNA, Complementary
1
2004
135
0.010
 Why?
Dose-Response Relationship, Drug
1
2007
1378
0.010
 Why?
Young Adult
1
2013
3981
0.010
 Why?
Recombinant Proteins
1
2004
487
0.010
 Why?
Randomized Controlled Trials as Topic
1
2005
550
0.010
 Why?
Solubility
1
2002
71
0.010
 Why?
Leukemia, Plasma Cell
1
2002
33
0.010
 Why?
Protein Structure, Tertiary
1
2002
253
0.010
 Why?
Adolescent
1
2013
6390
0.010
 Why?
Neoplasm Invasiveness
1
2002
266
0.010
 Why?
Retrospective Studies
1
2005
6134
0.010
 Why?
Yaccoby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (332) concept(s)
_
Co-Authors Expand Description
See all (29) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department